- ZVRA Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
8-K Filing Data
Zevra Therapeutics (ZVRA) 8-K13 Aug 24Zevra Therapeutics Reports Second Quarter 2024 Financial Results and FDA advisory committee voted favorably that the data support arimoclomol as effectiveFinancial data
Company Profile